Worldwide, cardiovascular diseases (CVDs) represent one of the main causes of morbidity and mortality, and acute coronary syndromes are responsible for a large number of sudden cardiac deaths. One of the main challenges that still exist in this area is represented by the early detection and targeted monitoring of the pathophysiology involved in CVDs. During the last couple of years, researchers have highlighted the importance of molecular and epigenetic mechanisms involved in the initiation and augmentation of CVDs, culminating in their most severe form represented by acute myocardial infarction. One of the most studied molecular factors involved in this type of pathology is represented by nuclear transcription factor kappa B (NF-κB), as well as the involvement of microRNAs (miRNAs). It has been suggested that miRNAs can also be involved in the complex process of atheromatous plaque vulnerabilization that leads to an acute cardiac event. In this review paper, we describe the most important molecular mechanisms involved in the pathogenesis of CVDs and atheromatous plaque progression and vulnerabilization, which include molecular mechanisms dependent on NF-κB. For this paper, we used international databases (PubMed and Scopus). The keywords used for the search were "miRNAs biomarkers", "miRNAs in cardiovascular disease", "NF-κB in cardiovascular disease", "molecular mechanism in cardiovascular disease", and "myocardial NF-κB mechanisms". Numerous molecular reactions that have NF-κB as a trigger are involved in the pathogenesis of CVDs. Moreover, miRNAs play an important role in initiating and aggravating certain segments of CVDs. Therefore, miRNAs can be used as biomarkers for early evaluation of CVDs. Furthermore, in the future, miRNAs could be used as a targeted molecular therapy in order to block certain mechanisms responsible for inducing CVDs and leading to acute cardiovascular events.
BACKGROUND
In the last years, worldwide, according to published stud- pathologies, such as ischemic heart disease, stroke, congestive heart failure, coronary heart disease, and rheumatic heart disease, most of them manifesting as various types of cardiovascular emergencies. [1] [2] [3] [4] If we were to talk about the most common pathology involved in the development and augmentation of CVDs, the pro-inflammatory component stands in the first line. 5 It is well known that in certain situations, inflammation can be beneficial for defense and tissue-remodeling mechanisms. However, when the inflammation becomes overexpressed or chronic, it is responsible of inducing certain pathological phenomena at myocardial level. Among these phenomena, the most commonly mentioned are ischemia-reperfusion syndrome (IR), myocardial infarction, atherosclerosis, aortic valve disorder, and heart failure. [6] [7] [8] [9] Therefore, the role of inflammation in triggering an acute cardiac condition is currently well established.
One of the main pathologies developed at cardiovascular level is represented by atherosclerosis, which eventually can be defined as a molecular and cellular inflammation complex. [10] [11] [12] [13] Of course, if we were to look at a molecular and cellular level, the vascular endothelium is the main involved cofactor. From a molecular viewpoint, the key player is represented by nuclear transcription factor kappa B (NF-κB), which, according to recent studies, is responsible for the modulation of molecular and epigenetic signals at this level. 14, 15 In this paper, we aim to present the most complex molecular mechanisms involved in the development and augmentation of CVDs and especially their most severe forms of manifestation, represented by acute cardiovascular events. Moreover, we wish to highlight a series of biomarkers that could be used in the early diagnosis and monitoring of CVDs. ncRNAs form a large family, comprising of ribosomal RNAs (rRNAs), small nucleolar RNAs (snoRNAs), transfer RNAs (tRNAs), and small nuclear RNAs (snRNAs).
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Moreover, ncRNAs can be divided depending on their main mechanisms of action. [34] [35] [36] [37] [38] [39] Among these, we mention the 
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Another important factor involved in the molecular mechanisms that lay at the basis of cardiovascular diseases is represented by nuclear factor kappa B (NF-κB). conclude that NF-κB is involved in most pro-and antiinflammatory processes underlying CVDs. Moreover, by using the expression of certain specific miRNAs, we can prevent certain cardiovascular pathologies, and we can choose the most appropriate therapeutic interventions in order to block molecular damage patterns. However, further research regarding the usage of these epigenetic species in the therapy of CVDs, and especially of acute coronary syndromes, is necessary.
